BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6221551)

  • 1. In vivo and in vitro actions of a new selective inhibitor of leukotriene C and D synthesis.
    Bach MK; Brashler JR; Fitzpatrick FA; Griffin RL; Iden SS; Johnson HG; McNee ML; McGuire JC; Smith HW; Smith RJ; Sun FF; Wasserman MA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():39-44. PubMed ID: 6221551
    [No Abstract]   [Full Text] [Related]  

  • 2. 6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies.
    Bach MK; Brashler JR; Smith HW; Fitzpatrick FA; Sun FF; McGuire JC
    Prostaglandins; 1982 May; 23(5):759-71. PubMed ID: 6812165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene C synthetase, a special glutathione S-transferase: properties of the enzyme and inhibitor studies with special reference to the mode of action of U-60,257, a selective inhibitor of leukotriene synthesis.
    Bach MK; Brashler JR; Peck RE; Morton DR
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):353-7. PubMed ID: 6381574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis of 6,9-deepoxy-6,9-N-phenylimino-delta 6,8-prostaglandin I1. A novel inhibitor of leukotriene C and D synthesis.
    Smith HW; Bach MK; Harrison AW; Johnson HG; Major NJ; Wasserman MA
    Prostaglandins; 1982 Oct; 24(4):543-6. PubMed ID: 6817384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization of leukotriene-forming enzymes.
    Jakschik BA; Kuo CG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():141-5. PubMed ID: 6221516
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboxane and leukotriene generation by mononuclearcytes from cardiac transplant patients.
    Zhao Y; Katz N; Lefrak E; Macoviak J; Foegh M
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():649-53. PubMed ID: 1825392
    [No Abstract]   [Full Text] [Related]  

  • 7. Piriprost: a selective inhibitor of leukotriene synthesis.
    Bach MK; Bowman BJ; Brashler JR; Fitzpatrick FA; Griffin RL; Johnson HG; Major NJ; McGuire JC; McNee ML; Richards IM
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():225-7. PubMed ID: 2936098
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies with inhibitors of sulfidopeptide leukotriene synthesis.
    Bach MK; Brashler JR
    Prog Clin Biol Res; 1985; 199():85-99. PubMed ID: 2866540
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation of leukotrienes C and D and Pharmacologic modulation of their synthesis.
    Bach MK; Brashler JR; Morton DR; Steel LK; Kaliner MA; Hugli TE
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():103-14. PubMed ID: 6124095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization and characterization of the leukotriene C4 synthetase of rat basophil leukemia cells: a novel, particulate glutathione S-transferase.
    Bach MK; Brashler JR; Morton DR
    Arch Biochem Biophys; 1984 May; 230(2):455-65. PubMed ID: 6324687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of a new, novel inhibitor of leukotriene synthesis in rhesus monkey Ascaris reactors.
    Johnson HG; McNee ML; Bach MK; Smith HW
    Int Arch Allergy Appl Immunol; 1983; 70(2):169-73. PubMed ID: 6337108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin F2 alpha, prostacyclin, and leukotriene C4 on the contractile activity of human uterine arteries.
    Vincent JE; Wallenburg HC; Zijlstra FJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():417-22. PubMed ID: 6221625
    [No Abstract]   [Full Text] [Related]  

  • 13. A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitor.
    Farina PR; Graham AG; Homon CA; Lazer ES; Hattox SE; Riska PS; Gundel RH; Wegner CD
    J Pharmacol Exp Ther; 1993 May; 265(2):483-9. PubMed ID: 8388452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and metabolism of prostaglandins, prostacyclin, and thromboxanes: the arachidonic acid cascade.
    Ramwell PW; Foegh M; Loeb R; Leovey EM
    Semin Perinatol; 1980 Jan; 4(1):3-13. PubMed ID: 6247764
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of benzydamine on leukotriene biosynthesis by basophilic leukemia cells.
    Bernström K; Hammarström S; Catanese B
    Boll Chim Farm; 1985 May; 124(5):187-9. PubMed ID: 3931658
    [No Abstract]   [Full Text] [Related]  

  • 16. SRS-A of rat basophil leukemia cells and rat mast cells.
    Parker CW
    Kroc Found Ser; 1981; 14():23-36. PubMed ID: 6947073
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prostaglandins and leukotrienes].
    Damas J
    Ann Biol Clin (Paris); 1984; 42(1):31-4. PubMed ID: 6329039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and endothelial stability.
    Hladovec J
    Arzneimittelforschung; 1981; 31(1):46-8. PubMed ID: 7011332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis and metabolism of leukotrienes.
    Hammarström S
    Monogr Allergy; 1983; 18():265-71. PubMed ID: 6316129
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.